Unlock instant, AI-driven research and patent intelligence for your innovation.
Cis-dammine dichloroplatinum prodrug, preparation method and application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A cisplatin and drug technology, applied in the field of medicinal chemistry and preparation, can solve the problems of poor water solubility of cisplatin, poor drug stability, low maximum tolerated dose, etc. Effect
Inactive Publication Date: 2018-12-18
ZHEJIANG UNIV
View PDF1 Cites 10 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1 2
[0060] The synthesis of embodiment 1 dihydroxy diamine dichloroplatinum II, such as figure 1 Shown:
[0061] A 100 mL round bottom flask was charged with CDDP (1 g, 3.33 mmol) and 15 ml of 30% hydrogenperoxide (30%, w / v). Stir at 75°C in the dark for 5 hours, cool at 4°C for 2 hours, filter under reduced pressure to obtain light yellow crystals, wash with water, ethanol and ether, and dry to obtain product II (998 mg, yield 90%).
Embodiment 2
[0062] Example 2 Synthesis of CDDP prodrug 1 containing saturated alkane chain compound, such as figure 2 Shown:
[0063] Add II (100mg, 0.3mmol) and n-hexanoic anhydride (127mg, 0.6mmol) to a 100mL round bottom flask, dissolve in (DMF), and add N,N'-dicyclohexylcarbodiimide (0.3mmol). Stir at 70°C for 3 hours. After the reaction, add water to precipitate a light yellow solid; then wash with water and petroleumether, and filter to obtain product 1 (95 mg, yield 60%).
[0064] product 1 1 The H NMR nuclear magnetic data is as follows:
[0065] 1 H NMR(400MHz,DMSO-d6):δ0.84-0.88(t,6H),1.23-1.27(m,8H),1.42-1.51(m,4H),2.16-2.22(m,4H),6.38- 6.63 (m, 6H).
Embodiment 3
[0066] Example 3 Synthesis of CDDP prodrug 2 containing saturated alkane chain compound, such as image 3 Shown:
[0067] In a 100 mL round bottom flask, add II (100 mg, 0.3 mmol) and n-heptanoic anhydride (146 mg, 0.6 mmol), dissolve in 2 mL of anhydrousdimethylformamide (DMF), add 1-(3-dimethylaminopropyl )-3-Ethylcarbodiimide (0.3 mmol). Stir at 70°C for 3 hours, add water to precipitate after the reaction to obtain a yellowish solid; then wash with water and petroleumether, and filter to obtain product 2 (109 mg, yield 65%).
[0068] product 2 1 The H NMR nuclear magnetic data is as follows:
[0069] 1 H NMR(400MHz,DMSO-d6):δ0.83-0.88(t,6H),1.21-1.25(m,12H),1.41-1.50(m,4H),2.17-2.22(m,4H),6.39- 6.63 (m, 6H).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
particle size
aaaaa
aaaaa
Login to View More
Abstract
The invention discloses a cis-dammine dichloroplatinum (CDDP) prodrug, a preparation method and application. The structural formula of the CDDP prodrug is shown as formula (I), and is generated by theesterification reaction of activated dihydroxy cisplatin with hydrophobic molecules. Characterization of the nano-preparation by dynamic light scattering and transmission electron microscopy indicates that the nanoparticles involved in the invention are uniformly distributed and are at about 30nm. In vitrocytotoxicity experiments show that the nano-drug can significantly inhibit the proliferation of tumor cells (A549 and LoVo). In vivo experiments show that compared with CDDP injections, on the basis of reducing the systemic toxicity, the nano-drug has the effect of inhibiting the non-smallcell lungcancer A549 subcutaneous tumor, and has good market prospects and clinical application value.
Description
technical field [0001] The invention belongs to the field of medicinal chemistry and preparation, and specifically relates to a series of cisplatindrug prodrugs, their preparation method and application. Background technique [0002] Cis-diammine dichloroplatinum (cis-damminedichloroplatinum (II), cis-Pt (II) (NH 3 ) 2 Cl 2 , CDDP) is a heavy metal compound that is centered on divalentplatinum and coordinated with two amino molecules and two chlorine atoms respectively. It was approved for clinical use by the U.S. Food and Drug Administration in 1978 ( Bristol-Myers Squibb). Its structural formula is as follows: [0003] [0004] As a clinical chemotherapy drug, CDDP is widely used in the treatment of osteosarcoma, soft tissue tumors such as testicular cancer, ovarian cancer, head and neck squamous cellcarcinoma and lungcancer (Ana-Maria Florea and Dietrica Büsselbery, Cisplatinas an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induce S...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
